Frank Rimerman Advisors’s Sanofi SNY Stock Holding History

Frank Rimerman Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,266	Closed	-$497K	–	641
2025 Q4	$497K	Buy	+10,266	New	+$509K	0.03%	386
2025 Q3	–	Sell	-5,396	Closed	-$261K	–	621
2025 Q2	$261K	Buy	+5,396	New	+$276K	0.02%	489
2024 Q3	–	Sell	-7,714	Closed	-$374K	–	563
2024 Q2	$374K	Buy	+7,714	New	+$372K	0.03%	406

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Frank Rimerman Advisors's SNY Position: Q1 2026 in Review

Frank Rimerman Advisors sold out of Sanofi (SNY) in Q1 2026, closing a stake of 10,266 shares — an estimated $497K sold.

Frank Rimerman Advisors first reported a position in SNY in Q2 2024 and held it in 3 quarters. The position peaked at $497K in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Frank Rimerman Advisors reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
Frank Rimerman Advisors sold 10,266 Sanofi shares in Q1 2026, an estimated $497K.
Frank Rimerman Advisors first reported a position in Sanofi in Q2 2024 and held it in 3 quarters.
Frank Rimerman Advisors's Sanofi position peaked at $497K in Q4 2025.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.